MicroRNAs as immune regulators and biomarkers in tuberculosis

Front Immunol. 2022 Oct 27:13:1027472. doi: 10.3389/fimmu.2022.1027472. eCollection 2022.

Abstract

Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), is one of the most lethal infectious disease worldwide, and it greatly affects human health. Some diagnostic and therapeutic methods are available to effectively prevent and treat TB; however, only a few systematic studies have described the roles of microRNAs (miRNAs) in TB. Combining multiple clinical datasets and previous studies on Mtb and miRNAs, we state that pathogens can exploit interactions between miRNAs and other biomolecules to avoid host mechanisms of immune-mediated clearance and survive in host cells for a long time. During the interaction between Mtb and host cells, miRNA expression levels are altered, resulting in the changes in the miRNA-mediated regulation of host cell metabolism, inflammatory responses, apoptosis, and autophagy. In addition, differential miRNA expression can be used to distinguish healthy individuals, patients with TB, and patients with latent TB. This review summarizes the roles of miRNAs in immune regulation and their application as biomarkers in TB. These findings could provide new opportunities for the diagnosis and treatment of TB.

Keywords: Mycobacterium tuberculosis; biomarkers; host immunity; immune regulators; microRNA.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism
  • Humans
  • Immunologic Factors
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / genetics
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Mycobacterium tuberculosis* / genetics
  • Tuberculosis* / diagnosis
  • Tuberculosis* / genetics

Substances

  • MicroRNAs
  • Biomarkers
  • Immunologic Factors